Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 180 days
Awards & highlights
Study Summary
This trial is testing a new type of feeding tube disk to see if it is more effective than the current one in healing and reducing complications.
Who is the study for?
This trial is for adults aged 22 or older who are about to receive a PEG tube or PEJ tube for feeding. It's not open to those who've had an enteral tube before, any gastric surgery like bariatric surgery, or used tobacco or illegal drugs in the past year.Check my eligibility
What is being tested?
The study is examining a new type of adjustable skin disk called Constant Pressure Skin Disk (CPSD) that's part of a feeding tube setup. The goal is to see if CPSD can help with better healing and fewer complications compared to current options.See study design
What are the potential side effects?
Potential side effects aren't specified but may include irritation at the site where the feeding tube enters the skin, infection risk, discomfort from pressure changes, and possible interference with wound healing.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 180 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~180 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Constant Pressure Skin Disk (CPSD) durability
Secondary outcome measures
Adverse Events
Trial Design
1Treatment groups
Experimental Treatment
Group I: Gastrostomy TubeExperimental Treatment1 Intervention
Non-hospitalized outpatients undergoing placement of a gastrointestinal gastrostomy tube (GIG tube) or GI jejunostomy tube (GIJ tube) will receive the usual Standards of Care related to the placement of a GIG or GIJ tube and the Constant Pressure Skin Disk.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,210 Previous Clinical Trials
3,767,137 Total Patients Enrolled
Manpreet S Mundi, MDPrincipal InvestigatorMayo Clinic
2 Previous Clinical Trials
72 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You recently had a tube inserted through your abdomen to help with feeding or medication.You have used tobacco or illegal drugs within the last year.
Research Study Groups:
This trial has the following groups:- Group 1: Gastrostomy Tube
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is participation in this research still available to those interested?
"According to the data hosted on clinicaltrials.gov, this medical trial is currently recruiting for participants. It was initially posted September 30th 2019 and recently updated March 7th 2022."
Answered by AI
What is the participant count for this research effort?
"Affirmative, the information on clinicaltrials.gov confirms that this study is recruiting at present. Initially published on September 30th 2019, it was most recently revised on March 7th 2022 and requires 20 participants to be recruited from a single location."
Answered by AI
Share this study with friends
Copy Link
Messenger